Automated immunoassay system for rapid blood-based diagnosis of traumatic brain injury using dual biomarkers (GFAP and UCH-L1). The VEUS platform delivers results within 15-50 minutes with high sensitivity and multiplexing capability, utilizing magnetic particle technology for accurate point-of-care...
Manufactured by
South Korea
VEUS, the abbreviation of Versatile, Easy, and User-friendly System, is a diagnostic system: Versatile – almost all in vitro diagnostic items are applicable; Easy – the system entirely automated enabling easy testing with no pretreatment required; User-friendly – anybody can use the system easily. Furthermore, it delivers rapid and accurate results for efficient clinical decision-making.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shi Ji Yi kang (Tianjin) Medical Technology Development Co., Ltd.
China · 1 relevant product
Lansion Biotechnology Co., Ltd.
China · 2 relevant products
Rapid Technology LLC
Russia · 2 relevant products
ABCDx
Spain · 3 relevant products
INTA S.r.l.
Italy · 2 relevant products
GenSure Biotech Inc.
China · 1 relevant product
S&T BioMed CO., LTD.
Taiwan · 1 relevant product
Brainsecrets.co.,Ltd
South Korea · 1 relevant product
Quidel China Ltd.
China · 1 relevant product
neuroClues SRL
Belgium · 1 relevant product
9 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →1 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 27 closest product alternatives
Shi Ji Yi kang (Tianjin) Medical Technology Development Co., Ltd. · China
POCT for assessing coagulation and thrombotic risk in stroke and cerebrovascular disease patients. Guides anticoagulation therapy and prevents recurrent cerebrovascular events. Applicable in neurology and stroke units.
Lansion Biotechnology Co., Ltd. · China
In vitro diagnostic reagent for neurological injury assessment. Supports rapid detection of brain injury biomarkers.
Rapid Technology LLC · Russia
Point-of-care diagnostic test for detecting ischemic stroke and traumatic brain injury based on biomarkers.
Rapid Technology LLC · Russia
Rapid diagnostic test for assessment of traumatic brain injury using key biomarkers.
ABCDx · Spain
A point-of-care diagnostic solution powered by advanced blood-based biomarkers for brain injuries. LVOCheck is designed for the selection and triage of large vessel occlusion (LVO) stroke patients to identify those requiring rapid treatment. The platform utilizes proprietary Software as a Medical Device technology to differentiate between ischemic and haemorrhagic stroke and detect mild traumatic brain injury.
INTA S.r.l. · Italy
A specialized diagnostic test detecting up to six traumatic brain injury biomarkers from a single drop of blood using the NanoAnalyzer platform. Results are displayed within minutes via AI-powered analysis, enabling rapid clinical decision-making in emergency settings.
Lansion Biotechnology Co., Ltd. · China
In vitro diagnostic reagent for neurological assessment. Provides rapid detection of nervous system biomarkers.
GenSure Biotech Inc. · China
Diagnostic test kit for measurement of biomarkers associated with cerebrovascular disease and stroke risk. Facilitates assessment of neurological and cerebrovascular health status.
S&T BioMed CO., LTD. · Taiwan
Automated immunoassay system utilizing electrochemical detection methods for biomarker quantification. Suitable for high-throughput clinical laboratory applications.
Brainsecrets.co.,Ltd · South Korea
System for identifying and analyzing neurobiological markers in EEG and physiological data for clinical diagnosis and treatment monitoring.
Quidel China Ltd. · China
Cardiac Injury Triple Test Kit using fluorescence immunoassay technology for rapid detection of cardiac biomarkers. Enables simultaneous measurement of multiple cardiac injury markers to support acute coronary syndrome diagnosis and risk stratification in clinical laboratory and point-of-care settings.
neuroClues SRL · Belgium
Non-invasive clinical assessment tool utilizing eye movement biomarkers to aid in diagnosis of neurological diseases. Provides objective measurements for disease progression monitoring and treatment efficacy evaluation with research-grade temporal and spatial resolution.
15 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products